Skip to content

A Study on the Role of Sol Remedy in the Management of Migraine among Adults Aged 18 to 50 Years.

An exploratory study on the role of Sol, an Imponderabilia remedy, in managing Migraine among adults aged 18-50 years using the MIDAS Scale - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099787
Enrollment
50
Registered
2025-12-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

Intervention1: Sol (Sunlight): Selection of potency and repetition will be according to the homoeopathic principles. Each dose will be directed to be taken orally on clean tongue with empty stomach. F

Sponsors

Jawaharlal Nehru Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient of age group 18-50 years irrespective of gender or socioeconomic status. 2. Patient diagnosed with clinical symptoms of Migraine as per ICHD. 3. Individuals with symptoms similar to Sol: Violent headache from vertex to forehead; headache triggered or aggravated by light; extreme sensitivity to light/photophobia. 4. Voluntary participation with written informed consent obtained before enrollment.

Exclusion criteria

Exclusion criteria: 1. Patient with severe neurological condition requiring specialized treatment. 2. Pregnant and Lactating women.

Design outcomes

Primary

MeasureTime frame
No Improvement Mild Improvement Moderate Improvement Significant Improvement Any increase in the MIDAS Score will be counted as worse.Timepoint: 12 weeks

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Garima Singh

Jawaharlal Nehru Homoeopathic Medical College and Hospital

krishna.raj93649@paruluniversity.ac.in7383869199

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026